Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation-Reference-Cited by-同舟云学术

Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation

Published:2016-06 Issue:6 Volume:18 Page:627-634
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Pelletier Sylvie,Wong Nora,El Haffaf Zaki,Foulkes William D.,Chiquette Jocelyne,Hamet Pavel,Simard Jacques,Dorval Michel

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/gim2015135.pdf

Reference34 articles.

1. National Institute for Health and Care Excellence (NICE). Familial breast cancer. Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. NICE Clinical Guideline 164. 2013.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated With Breast Cancer Screening Behaviors Among Women With Dense Breasts;Journal of Breast Imaging;2023-02-01

2. Impact of BRCA1/2 cascade testing on anxiety, depression, and cancer worry levels among unaffected relatives in a multiethnic Asian cohort;Journal of Genetic Counseling;2022-08

3. Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings;BMC Medical Genomics;2021-06-26

4. Survey of primary care physicians’ views about breast and ovarian cancer screening for true BRCA1/2 non-carriers;Journal of Community Genetics;2019-10-28

5. No Evidence of Excessive Cancer Screening in Female Noncarriers from BRCA1/2 Mutation–Positive Families;Current Oncology;2017-12-01